There were significant changes in pancreatic and intestinal hormones, particularly a marked elevation in the gastric inhibitory peptide (GIP), which is believed to have a significant contribution to post-pancreatitis diabetes (a specific type of DEP). This evidence concerns the gene GIP and pancreatitis.